FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
schedule
18:56
visibility
41 浏览
来源: Wired
阅读原文 →
auto_awesome 本文由机器自动翻译，可能存在不准确之处。
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.